When should genetic testing be performed in patients with neuroendocrine tumours?
Crossref DOI link: https://doi.org/10.1007/s11154-017-9430-3
Published Online: 2017-09-30
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O’Shea, Triona
Druce, Maralyn
Funding for this research was provided by:
Queen Mary University of London
License valid from 2017-09-30